[go: up one dir, main page]

HK1089105B - 供注射用的长春氟宁医药组合物的制备方法及其使用 - Google Patents

供注射用的长春氟宁医药组合物的制备方法及其使用 Download PDF

Info

Publication number
HK1089105B
HK1089105B HK06110282.0A HK06110282A HK1089105B HK 1089105 B HK1089105 B HK 1089105B HK 06110282 A HK06110282 A HK 06110282A HK 1089105 B HK1089105 B HK 1089105B
Authority
HK
Hong Kong
Prior art keywords
vinflunine
composition according
ditartrate
buffer
water
Prior art date
Application number
HK06110282.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1089105A1 (zh
Inventor
Elie Leverd
Joël BOUGARET
Marie-Dominique Ibarra
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0315312A external-priority patent/FR2863891B1/fr
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of HK1089105A1 publication Critical patent/HK1089105A1/zh
Publication of HK1089105B publication Critical patent/HK1089105B/zh

Links

HK06110282.0A 2003-12-23 2004-12-17 供注射用的长春氟宁医药组合物的制备方法及其使用 HK1089105B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0315312 2003-12-23
FR0315312A FR2863891B1 (fr) 2003-12-23 2003-12-23 Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
PCT/FR2004/003287 WO2005070425A1 (fr) 2003-12-23 2004-12-17 Composition pharmaceutique de vinflunine destinee a une administration parenterale, procede de preparation et utilisation

Publications (2)

Publication Number Publication Date
HK1089105A1 HK1089105A1 (zh) 2006-11-24
HK1089105B true HK1089105B (zh) 2009-07-17

Family

ID=

Similar Documents

Publication Publication Date Title
JP5710462B2 (ja) 非経口投与を目的とするビンフルニンの医薬組成物、その調製方法およびその使用
EP1052974B1 (en) Pharmaceutical formulation containing epothilone
ES2223549T3 (es) Formulacion que contiene moxifloxacino y sal comun.
EP2525796B1 (en) Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
EP1368019B2 (en) Esmolol formulation
US4619935A (en) Stable oncolytic formulations
HK1089105B (zh) 供注射用的长春氟宁医药组合物的制备方法及其使用
HU191538B (en) Process for producing pharmaceutical compositions containing acid additional salts of vinca-dimeres
US4915956A (en) Liquid cisplatin formulations
EP0334551B1 (en) Anti-neoplastic formulations
CN101090708A (zh) 用于奥沙利铂溶液的塑料瓶
JPH03130226A (ja) １つより多いエチレンイミン基を有する抗新生物性化合物用の安定な製薬学的配合及び方法
US20110015221A1 (en) Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
EP1800664B1 (en) Pharmaceutical formulations for parenteral administration comprising epothilone
EP3222271A1 (en) Stable pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salt thereof
EP2976063A1 (en) Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof
HK1105808B (zh) 非胃肠给药方式使用的含有依蒲赛龙的药物制剂
HK1105808A1 (zh) 非胃肠给药方式使用的含有依蒲赛龙的药物制剂
HK1119562A (zh) 麦角灵化合物的稳定水溶液
HK1033809B (zh) 含有依宝雪龙的药用加工制剂